Results 161 to 170 of about 7,371 (206)

Impact of dose and compliance of antidementia medications on long-term outcomes in Alzheimer's disease: a nationwide real-world study. [PDF]

Alzheimers Res Ther
Kim T, Hong YJ, Kim M, Bae Y, Lee SB, Kim SH, Lee MA, Ko E, Park JW, Yang DW.   +9 more
europepmc   +1 more source

The Mediterranean Species Calendula officinalis and Foeniculum vulgare as Valuable Source of Bioactive Compounds. [PDF]

Molecules
Vella FM, Pignone D, Laratta B.
europepmc   +1 more source

Unlocking vinpocetine's oncostatic potential in early-stage hepatocellular carcinoma: A new approach to oncogenic modulation by a nootropic drug. [PDF]

PLoS One
Mohammed OA, Youssef ME, Hamad RS, Abdel-Reheim MA, Saleh LA, Alamri MMS, Alharthi MH, Alfaifi J, Adam MIE, Eleragi AMS, Senbel A, Farrag AA, Rezigalla AA, El-Wakeel HS, Attia MA, El-Husseiny HM, Al-Noshokaty TM, Doghish AS, Gaafar AGA, Saber S.   +19 more
europepmc   +1 more source

Adulteration of Brain Health (Cognitive, Mood, and Sleep Enhancement) Food Supplements by the Addition of Pharmaceutical Drugs: A Comprehensive Review of Analytical Approaches and Trends. [PDF]

Foods
Paiva R, Correia M, Delerue-Matos C, Amaral JS.   +3 more
europepmc   +1 more source

The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease. [PDF]

Acta Naturae
Radchenko AI, Kuzubova EV, Apostol AA, Mitkevich VA, Andreeva LA, Limborska SA, Stepenko YV, Shmigerova VS, Solin AV, Korokin MV, Pokrovskii MV, Myasoedov NF, Makarov AA.   +12 more
europepmc   +1 more source

Components of evoked hyperpolarization in the spinal motoneuron of the cat [PDF]

, 1980
Aranibar, Alberto, Lechner, Helmut, Sutor, Bernd, Vieth, J.   +3 more
core  

Differential cognitive enhancer effects of acetylcholinesterase inhibitors and memantine on age-related deficits in vigilance and sustained attention: a preclinical validation study. [PDF]

Behav Brain Funct
Bali ZK, Bruszt N, Göntér K, Hernádi I.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Avoidance facilitation by nootropics

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1989
1. The effects on avoidance acquisition of two nootropic drugs, oxiracetam and piracetam, were tested in mice subjected to five daily 100-trial training sessions in the shuttle-box. 2. Oxiracetam (25 or 50 mg/kg/i.p.) and piracetam (100 mg/kg/i.p.), given before each daily session, improved avoidance acquisition in the good performing BALB/c more than ...
M, Sansone, A, Oliverio
openaire   +2 more sources

Towards Better Brain Management: Nootropics

Current Medicinal Chemistry, 2007
The learning and memory deficits have been recognized as severe and consistent neurological disorders associated with numerous neurodegenerative states. Research in this area has gained momentum only in the recent past after the biochemical and physiological basis of these processes have been understood.
Ruchi, Malik, Abhijeet, Sangwan, Ruchika, Saihgal, Dharam Paul, Jindal, Poonam, Piplani   +4 more
openaire   +2 more sources

Nootropics

2002
Abstract The term ‘nootropics’ (from Greek, noos—mind, tropos—turn) was originally coined to denote chemical compounds that were reported to enhance cognitive function, including learning and memory, without possessing other significant effects (Giurgea 1973). The best known are piracetam and structurally related compounds (Giurgea 1973;
openaire   +1 more source